Filing
2nd Quarter - Report
Lobbying activity
1
Issues related to the Vaccine Injury Compensation Program (VICP); Issues related to Pandemic and All Hazards Preparedness Act (PAHPA) reauthorization; Issues related to bivalent vaccines; Issues related to the expiration/extension of Priority Review Vouchers (PRVs) for rare disease; Issues related to 2024 Physician Fee Schedule; H.R. 946/S. 1862, Orphan Cures Act